Scholl, Claudia
German Cancer Research Center · Heidelberg University · University Hospital Heidelberg · National Center for Tumor Diseases · Deutsches Konsortium für Translationale Krebsforschung
7 papers on CoChatORCID 0000-0001-6768-322X
Most cited papers
- Verified
Accurate and efficient detection of gene fusions from RNA sequencing data
Uhrig, S., Ellermann, J., Walther, T., Burkhardt, P., Fröhlich, M., Hutter, B., Toprak, U. H., Neumann, O., Stenzinger, A., Scholl, C., et al. (2021) · Genome Research
Cancer Genomics and DiagnosticsGenomics and Phylogenetic Studies
Cited by 526
- Verified
The CDK inhibitor CR8 acts as a molecular glue degrader that depletes cyclin K
Słabicki, M., Kozicka, Z., Petzold, G., Li, Y.-D., Manojkumar, M., Bunker, R. D., Donovan, K. A., Sievers, Q. L., Koeppel, J., Suchyta, D., et al. (2020) · Nature
Protein Degradation and InhibitorsUbiquitin and proteasome pathways
Cited by 433
- Verified
BCAT1 restricts αKG levels in AML stem cells leading to IDHmut-like DNA hypermethylation
Raffel, S., Falcone, M., Kneisel, N., Hansson, J., Wang, W., Lutz, C., Bullinger, L., Poschet, G., Nonnenmacher, Y., Barnert, A., et al. (2017) · Nature
Acute Myeloid Leukemia ResearchEpigenetics and DNA Methylation
Cited by 354
- Verified
Small-molecule-induced polymerization triggers degradation of BCL6
Słabicki, M., Yoon, H., Koeppel, J., Nitsch, L., Roy Burman, S. S., Di Genua, C., Donovan, K. A., Sperling, A. S., Hunkeler, M., Tsai, J. M., et al. (2020) · Nature
Protein Degradation and InhibitorsUbiquitin and proteasome pathways
Cited by 270
- Verified
Requirement for CDK6 in MLL-rearranged acute myeloid leukemia
Placke, T., Faber, K., Nonami, A., Putwain, S. L., Salih, H. R., Heidel, F. H., Krämer, A., Root, D. E., Barbie, D. A., Krivtsov, A. V., et al. (2014) · Blood
Acute Myeloid Leukemia ResearchChromatin Remodeling and Cancer
Cited by 170
- Verified
Requirement for YAP1 signaling in myxoid liposarcoma
Trautmann, M., Cheng, Y., Jensen, P., Azoitei, N., Brunner, I., Hüllein, J., Slabicki, M., Isfort, I., Cyra, M., Berthold, R., et al. (2019) · EMBO Molecular Medicine
Hippo pathway signaling and YAP/TAZSarcoma Diagnosis and Treatment
Cited by 32
- Verified
Selective targeting of TBXT with DARPins identifies regulatory networks and therapeutic vulnerabilities in chordoma
Umbaugh, C. S., Groth, M., Erkut, C., Lee, K.-S., Marinho, J., Linder, S., Iser, F., Kapp, J. N., Schroeter, P., Dolaner, S., et al. (2025) · Science Advances
Bone Tumor Diagnosis and TreatmentsProtein Degradation and Inhibitors
Cited by 6
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free